Morgan Stanley
SNTI icon

Morgan Stanley’s Senti Biosciences Holdings SNTI Stock Holding History

Morgan Stanley’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186 Buy
169
+9
+6% +$9 ﹤0.01% 7854
2026
Q1 		$130 Hold
160
– – ﹤0.01% 7756
2025
Q4 		$166 Hold
160
– – ﹤0.01% 7650
2025
Q3 		$226 Hold
160
– – ﹤0.01% 7589
2025
Q2 		$338 Hold
160
– – ﹤0.01% 7504
2025
Q1 		$538 Hold
160
– – ﹤0.01% 7359
2024
Q4 		$562 Sell
160
-406
-72% -$1.3K ﹤0.01% 7332
2024
Q3 		$1.28K Buy
566
+26
+5% +$69 ﹤0.01% 7192
2024
Q2 		$1.49K Buy
540
+380
+238% +$1.23K ﹤0.01% 7106
2024
Q1 		$603 Buy
+160
New +$715 ﹤0.01% 7222
2023
Q4 		– Hold
0
– – – 7901
2023
Q3 		– Sell
-1,700
Closed -$11.7K – 7693
2023
Q2 		$10.7K Sell
1,700
-23,286
-93% -$227K ﹤0.01% 6795
2023
Q1 		$295K Sell
24,986
-232
-0.9% -$3.61K ﹤0.01% 5521
2022
Q4 		$356K Sell
25,218
-9,823
-28% -$240K ﹤0.01% 5407
2022
Q3 		$760K Sell
35,041
-59,945
-63% -$1.18M ﹤0.01% 5047
2022
Q2 		$1.87M Sell
94,986
-142,654
-60% -$11.5M ﹤0.01% 4583
2022
Q1 		$23.5M Sell
237,640
-51,423
-18% -$5.08M ﹤0.01% 1945
2021
Q4 		$28.5M Sell
289,063
-8
-0% -$798 ﹤0.01% 1793
2021
Q3 		$28.7M Sell
289,071
-352
-0.1% -$34.7K ﹤0.01% 1723
2021
Q2 		$28.8M Buy
+289,423
New +$28.9M ﹤0.01% 1778

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley's SNTI Position: Q2 2026 in Review

Morgan Stanley increased its Senti Biosciences Holdings (SNTI) stake by 5.6% in Q2 2026, buying an estimated $9 and bringing the position to 169 shares worth $186. The position accounts for ﹤0.01% of the portfolio, ranked #7854.

Morgan Stanley first reported a position in SNTI in Q2 2021 and has held it in 19 quarters since. The position peaked at $28.8M in Q2 2021. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Morgan Stanley held 169 shares of Senti Biosciences Holdings worth $186 as of Q2 2026.
  • Morgan Stanley bought 9 Senti Biosciences Holdings shares in Q2 2026, an estimated $9.
  • Senti Biosciences Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7854 holding.
  • Morgan Stanley first reported a position in Senti Biosciences Holdings in Q2 2021 and has held it in 19 quarters since.
  • Morgan Stanley's Senti Biosciences Holdings position peaked at $28.8M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.